Medicare Enrolled
Dr. Albert Ong, M.D.
Urology Physician · Orlando, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ong?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ong
Dr. Albert Ong is an urology physician in Orlando, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ong performed 5,983 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ong received a total of $85,125 from 66 pharmaceutical and/or device companies across 545 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ong is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 21% volume in FL
$85,125 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 108495 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗5,983
Medicare services
Top 21% in FL for urology physician
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,500 | $0 | $1 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
670 | $3 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
653 | $95 | $160 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
202 | $65 | $100 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
200 | $8 | $35 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
138 | $120 | $265 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
101 | $11 | $150 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
101 | $186 | $400 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
71 | $23 | $194 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
60 | $8 | $8 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
56 | $17 | $40 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
34 | $5 | $15 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
33 | $203 | $850 |
| Injection, garamycin, gentamicin, up to 80 mg | 31 | $2 | $10 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
30 | $82 | $430 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $137 | $235 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
20 | $23 | $60 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $99 | $435 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
15 | $24 | $262 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
14 | $11 | $35 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
13 | $336 | $1,200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.2% high complexity
65.4% medium
34.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$85,125
Total received (2018-2024)
Avg $12,161/year across 7 years
Top 4% in FL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
545
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,844
2023
$1,452
2022
$24,771
2021
$32,636
2020
$9,203
2019
$6,582
2018
$8,638
Payments by company (2024)
Stryker Corporation
$750
Myriad Genetic Laboratories, Inc.
$231
Ferring Pharmaceuticals Inc.
$88
PFIZER INC.
$79
Axonics, Inc.
$78
Janssen Biotech, Inc.
$70
Endo USA, Inc.
$67
Bayer Healthcare Pharmaceuticals Inc.
$64
Astellas Pharma US Inc
$55
Sumitomo Pharma America, Inc.
$55
ABC Home Medical Supply, Inc.
$53
Endo Pharmaceuticals Inc.
$49
Boston Scientific Corporation
$32
Merck Sharp & Dohme LLC
$27
Ambu Inc.
$27
ABBVIE INC.
$26
Teleflex LLC
$22
ACCORD HEALTHCARE, INC.
$21
Tolmar, Inc.
$19
Verity Pharmaceuticals Inc.
$16
BIOPROTECT MEDICAL, INC.
$14
Top 3 companies account for 58.0% of 2024 payments
All-time payments by company (2018-2024) ›
Stryker Corporation
$75,214
Astellas Pharma US Inc
$1,440
Endo Pharmaceuticals Inc.
$903
Myriad Genetic Laboratories, Inc.
$759
Janssen Biotech, Inc.
$741
Coloplast Corp
$444
TOLMAR Pharmaceuticals, Inc.
$369
Boston Scientific Corporation
$334
PFIZER INC.
$258
Dendreon Pharmaceuticals LLC
$249
Olympus America Inc.
$244
Acerus Pharmaceuticals Corporation
$231
Sumitomo Pharma America, Inc.
$224
Myovant Sciences Inc.
$223
Antares Pharma, Inc.
$217
Bayer HealthCare Pharmaceuticals Inc.
$208
COLOPLAST CORP
$193
Bayer Healthcare Pharmaceuticals Inc.
$164
Smith+Nephew, Inc.
$160
Axonics, Inc.
$160
Merck Sharp & Dohme LLC
$157
NeoTract Inc.
$134
Allergan Inc.
$131
C. R. Bard, Inc. & Subsidiaries
$127
Alnylam Pharmaceuticals Inc.
$114
Novartis Pharmaceuticals Corporation
$112
Ferring Pharmaceuticals Inc.
$106
Allergan, Inc.
$103
Teleflex LLC
$100
Blue Earth Diagnostics Limited
$95
ABBVIE INC.
$86
UroGen Pharma, Inc.
$80
Tolmar, Inc.
$73
Endo USA, Inc.
$67
Avadel Specialty Pharmaceuticals, LLC
$64
Ambu Inc.
$59
BOSTON SCIENTIFIC CORPORATION
$57
Integra LifeSciences Corporation
$56
ABC Home Medical Supply, Inc.
$53
AstraZeneca Pharmaceuticals LP
$50
KARL STORZ Endoscopy-America
$42
Kowa Pharmaceuticals America, Inc.
$41
AbbVie, Inc.
$37
Metuchen Pharmaceuticals
$35
Verity Pharmaceuticals Inc.
$33
Rochester Medical Corporation
$31
Photocure Inc
$23
Clarus Therapeutics Inc.
$22
Sagent Pharmaceuticals, Inc.
$22
ACCORD HEALTHCARE, INC.
$21
DAVOL INC.
$20
Accord Healthcare, Inc.
$19
180 Medical, Inc.
$19
EDAP TECHNOMED INC
$18
Medtronic, Inc.
$18
Wilmington Medical Supply, Inc.
$17
Olympus Corporation of the Americas
$17
Pacira Pharmaceuticals Incorporated
$16
Retrophin, Inc.
$15
AngioDynamics, Inc.
$15
ConvaTec Inc.
$15
Telix Pharmaceuticals
$15
Aytu BioScience, Inc
$14
BIOPROTECT MEDICAL, INC.
$14
Augmenix, Inc.
$14
Dornier MedTech America, Inc
$13
Top 3 companies account for 91.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 1788 · 24/26 FR. · 24FR BIPLR COAG ELECTRDE · ADSTILADRIN · AFINITOR · AIM (ADVANCED IMAGING MODALITY) · AIM LAPARASCOPES · ARISTA AH · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BIOFIX · BIOPROTECT BALLOON IMPLANT SYSTEM · BIPOLAR · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis CDx · CAMCEVI · CONTINENCE CARE · CUTTING LOOP · Consumables & Accessories · Cysview · EDEX · ELIGARD · ENDOBEAM · ERLEADA · EXPAREL · Erleada · FLEXIVA · GEMTESA · GENERAL THERAPIES · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · GENTLECATH · GREENLIGHT · Glydo · ILLUCCIX · INTERSTIM · IRIS · Isiris · JATENZO · JELMYTO · KEYTRUDA · LYNPARZA · LithoVue · Lupron · MYRBETRIQ · MYRISK · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Olympus Laparoscopic Accessories · Otrexup · PERFORMANCE SOLUTIONS · PICO 14 · PKG/6 · PLUVICTO · PROLARIS · PROVENGE · Prolaris · REZUM · ReTrace · SEGLENTIS · SPACEOAR · SPEEDICATH · SPY TECHNOLOGY · SPY-PHI SYSTEM · STERILE · Seglentis · SpaceOAR · SpeediCath · Stendra · TOVIAZ · Titan · Trelstar · UGN Laser Capital · UKIT · UROLIFT · UroLift · UroLift System · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · iTIND System · myRisk · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
97
County median income
$77,011
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ong is a clinical cardiology specialist, with above-average Medicare volume (top 21% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ong experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Ong performed 3,500 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ong receive payments from pharmaceutical companies?
Yes. Dr. Ong received a total of $85,125 from 66 companies across 545 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ong's costs compare to other urology physicians in Orlando?
Dr. Ong's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Orlando
Browse urology physicians in Orlando ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Stryker Corporation Payments to Doctors
See all physicians who received payments from Stryker Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology